Apr. 18, 2026
Holyoke Event Raises Funds for Cancer Support Organization
The 2nd Annual 'Cocktails for a Cause' Derby Kickoff Party will benefit 'Each Moment We're Alive' cancer support group.
Apr. 17, 2026
Foundation Medicine to Expand Monitoring Portfolio with SAGA Diagnostics' MRD Platform
Pathlight, a tumor-informed molecular residual disease (MRD) test, will strengthen Foundation Medicine's diagnostic offerings.
Apr. 17, 2026
Nested Therapeutics Reports Promising Early Results for Brain-Penetrant Pan-RAF/MEK Therapy
NST-628 demonstrates 38% response rate and 85% disease control rate in advanced NRAS and BRAF Class II/III melanoma patients
Apr. 17, 2026
Moderna Presents Phase 1/2 Data on Cancer Antigen Therapy
Investigational mRNA-4359 therapy shows promise in combination with pembrolizumab for advanced melanoma.
Apr. 16, 2026
Burlington Man Runs Boston Marathon to Honor Late Father
Adam Averback lost his father to brain cancer and was later diagnosed with testicular cancer himself, but is finding inspiration to run the iconic race.
Apr. 16, 2026
Revvity Unveils Cancer Research Innovations at AACR Conference
The biotech company is highlighting its latest tools and solutions for advancing cancer studies at the annual industry gathering.
Apr. 16, 2026
Study Finds Never-Married Adults Have Higher Cancer Risk
Marital status linked to differences in cancer incidence across multiple cancer types
Apr. 16, 2026
Boehringer Ingelheim and Zai Lab Collaborate on DLL3-Targeting Cancer Therapy
The companies will evaluate a combination of a T-cell engager and an antibody-drug conjugate in small cell lung cancer and other neuroendocrine carcinomas.
Apr. 15, 2026
Somerville Woman Rallies Community Support for Father's Cancer Battle
Jacqueline Haycox launches GoFundMe to offset medical and living expenses as her father undergoes intensive treatment
Apr. 15, 2026
BostonGene and ImmunoGenesis Announce Strategic Partnership to Overcome Immunotherapy Resistance
Leveraging AI-Driven Multiomics and Spatial Biology to Unlock the Full Potential of Next-Generation Cytotoxic Dual Checkpoint Inhibitor
Apr. 14, 2026
Massachusetts Delays Vote on New Proton Beam Therapy Center
Public health panel cites concerns over equity and access to the advanced cancer treatment.
Apr. 14, 2026
Cambridge Biotech Harbinger Health Raises $100M to Launch 12-Cancer Blood Tests
The funding will support commercial-scale operations and regulatory work ahead of initial rollout of Harbinger's multi-cancer early detection platform.
Apr. 14, 2026
Harbinger Health Establishes RESOLVE™ as a New Category for Cancer Detection
Announces $100M financing to develop a portfolio of multi-cancer tests designed to reduce diagnostic uncertainty and delays
Apr. 14, 2026
£80M Boost for UK Life Sciences: Jobs & Key Medicines
Investments across the UK will deliver vaccines and medicines for conditions like cancer and bipolar disorder
